|
Beta Carotene Capsules » Beta Carotene Capsules contain not less than 90.0 percent and not more than 125.0 percent of the labeled amount of C40H56. Packaging and storage Preserve in tight, light-resistant containers. IdentificationGrind a portion of the Capsule contents, equivalent to about 10 mg of beta carotene, transfer to a centrifuge tube, add 5 mL of chloroform, shake for 1 minute, and centrifuge for 3 minutes. Filter the supernatant layer, collecting about 2 mL of the filtrate in a 25-mL conical flask. Add 5 mL of antimony trichloride TS to the filtrate: a transient purple or blue color forms. Uniformity of dosage units Assay [notePerform this procedure in subdued light, using low-actinic glassware. ] CyclohexaneSpectrophotometric grade, or material that has been purified by being passed through a column of activated silica gel and distilled. Iodine solutionTransfer about 10 mg of iodine into a 100-mL volumetric flask. Dissolve in cyclohexane, dilute with cyclohexane to volume, and mix. Dilute 10.0 mL of this solution with cyclohexane to 100 mL, and mix. Prepare this solution fresh daily. Assay preparationsCombine the contents of not fewer than 20 Capsules, and grind, using a freezer mill, to a fine powder of uniform color. Transfer an accurately weighed quantity of the finely ground capsule contents, equivalent to about 75 mg of beta carotene, to a 1000-mL volumetric flask, add 500 mL of water, and heat at 60 Standard preparationsAccurately weigh about 17 mg of Beta Carotene, previously subjected to the Assay and previously dried in vacuum over phosphorus pentoxide at 40 ProcedureConcomitantly measure the absorbances of Assay preparation 3 and Standard preparation 2 at 452 nm, with a suitable spectrophotometer, using cyclohexane as the blank. Calculate the quantity, in mg, of C40H56 in the portion of Capsule contents taken by the formula: 40C(AU/AS) in which C is the concentration, in µg per mL, of Beta Carotene in the Standard preparation; and AU and AS are the absorbances of Assay preparation 3 and Standard preparation 2, respectively.Auxiliary InformationPlease check for your question in the FAQs before contacting USP.
USP35NF30 Page 2334 Pharmacopeial Forum: Volume No. 37(1) |